I agree that this site is using cookies. You can find further informations here.
X
Rotow, Julia K
21  results:
Articles (Online) X
Search for persons X
?
1

Focal adhesion kinase-YAP signaling axis drives drug-tolera..:

Haderk, Franziska ; Chou, Yu-Ting ; Cech, Lauren...
Nature Communications.  15 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
2

Real-World Genomic Profile of EGFR Second-Site Mutations an..:

Rotow, Julia K. ; Lee, Jessica K. ; Madison, Russell W....
Journal of Thoracic Oncology.  19 (2024)  2 - p. 227-239 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Genotype Versus Phenotype: Defining Predictive Biomarkers o..:

Makarem, Maisam ; Rotow, Julia K.
Journal of Thoracic Oncology.  18 (2023)  12 - p. 1615-1617 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Osimertinib in NSCLC With Atypical EGFR-Activating Mutation..:

Ji, Jingran ; Aredo, Jacqueline V. ; Piper-Vallillo, Andrew...
JTO Clinical and Research Reports.  4 (2023)  3 - p. 100459 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Pneumonitis in Patients Receiving Thoracic Radiotherapy and..:

Banla, Leou Ismael ; Tzeng, Alice ; Baillieul, John P....
JTO Clinical and Research Reports.  4 (2023)  10 - p. 100559 , 2023
Link: https://doi.org/10.1016/..
 
?
6

High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A..:

Piper-Vallillo, A.J. ; Rotow, Julia K. ; Aredo, Jacqueline V....
JTO Clinical and Research Reports.  3 (2022)  6 - p. 100328 , 2022
Link: https://doi.org/10.1016/..
 
?
7

Therapy-Induced Evolution of Human Lung Cancer Revealed by ..:

Maynard, Ashley ; McCoach, Caroline E. ; Rotow, Julia K....
Cell.  182 (2020)  5 - p. 1232-1251.e22 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Pathologic Complete Response to Neoadjuvant Crizotinib in a..:

Rotow, Julia K. ; Woodard, Gavitt A. ; Urisman, Anatoly...
Clinical Lung Cancer.  20 (2019)  2 - p. e137-e141 , 2019
Link: https://doi.org/10.1016/..
 
?
9

RBM5/H37 tumor suppressor, located at the lung cancer hot s..:

Oh, Juliana J. ; Taschereau, Eileen O. ; Koegel, Ashley K....
Lung Cancer.  70 (2010)  3 - p. 253-262 , 2010
Link: https://doi.org/10.1016/..
 
?
10

PPD01.07 Phase 2 Trial of Mecbotamab Vedotin (BA3011), a CA..:

Rotow, Julia ; Dy, Grace K. ; Camidge, D. Ross
Journal of Thoracic Oncology.  19 (2024)  7 - p. e7 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Deficiency of the splicing factor RBM10 limits EGFR inhibit..:

Nanjo, Shigeki ; Wu, Wei ; Karachaliou, Niki...
Journal of Clinical Investigation.  132 (2022)  13 - p. , 2022
Link: https://doi.org/10.1172/..
 
?
12

Evolution and clinical impact of co-occurring genetic alter..:

Blakely, Collin M ; Watkins, Thomas B K ; Wu, Wei...
Nature Genetics.  49 (2017)  12 - p. 1693-1704 , 2017
Link: https://doi.org/10.1038/..
 
?
13

The ASCENT Trial: a phase 2 study of induction and consolid..:

Chang, Allison E B ; Piper-Vallillo, Andrew J ; Mak, Raymond H...
The Oncologist.  29 (2024)  7 - p. 609-618 , 2024
Link: https://doi.org/10.1093/..
 
?
14

Treatment decision for recurrences in non-small cell lung c..:

Mirza, Myriam ; Shrivastava, Aseem ; Matthews, Cecile...
Frontiers in Oncology.  13 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
15

A dual pathway inhibition strategy using BKM120 combined wi..:

Algazi, Alain Patrick ; Rotow, Julia ; Posch, Christian...
Pigment Cell & Melanoma Research.  32 (2019)  4 - p. 603-606 , 2019
Link: https://doi.org/10.1111/..
 
1-15